http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4596710-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3ad73b7be255195d5862d0e67db94df
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
filingDate 1984-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1986-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_807709e37af6e0c6a46514f27a3e8db6
publicationDate 1986-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4596710-A
titleOfInvention Gallium chloride as a new anti-cancerous drug
abstract The present invention relates to the application of gallium chloride as drug particularly useful for the treatment of malignant tumors, and to the pharmaceutical compositions particularly intended for oral administration and containing from 100 to 500 mg of active ingredient per unit dose.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6087354-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7019156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5883088-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10116527-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10116527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5747482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6048851-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002160055-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4686104-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5258376-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5998397-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5574027-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5968922-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02081484-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5981518-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9117751-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7081247-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004110737-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6004951-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003215404-A1
priorityDate 1981-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53249521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136050722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226505236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66588494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23664211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226506678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23702402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9554281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129423977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396249

Total number of triples: 53.